Concert Pharmaceuticals, Inc.
DEUTERATED IDEBENONE
Last updated:
Abstract:
The present invention in one embodiment provides a compound of Formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.
Status:
Application
Type:
Utility
Filling date:
16 May 2019
Issue date:
5 Dec 2019